Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse-Reference-Cited by-同舟云学术

Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse

Published:2009-05 Issue:1 Volume:237 Page:83-90
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Kakiuchi-Kiyota Satoko,Vetro Joseph A.,Suzuki Shugo,Varney Michelle L.,Han Huai-Yun,Nascimento Merielen,Pennington Karen L.,Arnold Lora L.,Singh Rakesh K.,Cohen Samuel M.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference40 articles.

1. HMEC-1: establishment of an immortalized human microvascular endothelial cell line;Ades;J. Invest. Dermatol.,1992

2. Current status of carcinogenicity assessment of peroxisome proliferator-activated receptor agonists by the US FDA and a mode-of-action approach to the carcinogenic potential;Aoki;J. Toxicol. Pathol.,2007

3. The mechanisms of action of PPARs;Berger;Annu. Rev. Med.,2002

4. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism;Biscetti;Diabetes,2008

5. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta12, 14-prostaglandin J2;Bishop-Bailey;J. Biol. Chem.,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic effects of anti-diabetic drugs: A comprehensive review;European Journal of Pharmacology;2020-10

2. Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human;Archives of Toxicology;2018-03-19

3. From the Cover: Fenretinide, Troglitazone, and Elmiron Add to Weight of Evidence Support for Hemangiosarcoma Mode-of-Action From Studies in Mice;Toxicological Sciences;2017-09-18

4. Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite;Regulatory Toxicology and Pharmacology;2017-06

5. Peroxisome proliferator-activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor-, vascular endothelial growth factor- and angiopoietin-mediated signaling;Molecular Medicine Reports;2017-03